MES-like glioma cells expressed multiple receptors for ANGPTL4, including syndecans SDC2, SDC3, and SDC4 as well as WNT5A receptor FZD6 (Figure 4E), suggesting that these pathways may be responsible for the enrichment of GSCs in ECMhi tumors. Here, SDC4 is linked to central nervous system cancer.